ImpactAlpha, May 19 – Symbiotics invests in emerging markets’ microfinance institutions, small business banks, commercial banks with small business initiatives and leasing companies. The firm recently listed Symbiotics Sicav II, to make debt investments, including bonds, promissory notes and loan agreements, that provide financial institutions with access to capital.
As part ABN Amro’s growing impact investing strategy, the Dutch bank’s Emerging Markets Impact Debt fund will act as a feeder fund for Symbiotics Sicav II.